Comorbidities of obsessive and compulsive symptoms in Huntington's disease.
Although current reports document a high rate of obsessive and compulsive symptoms (O/Cs) in Huntington's disease (HD), there have been no studies published that have made an attempt to identify comorbidities of O/Cs in HD. We examined O/Cs in 1642 individuals with a diagnosis of HD. Of those endorsing significant O/Cs (27.2%), nearly one-quarter reported obtaining treatment for obsessive compulsive disorder. Individuals with HD and O/Cs were older, had poorer functioning, and a longer duration of illness than those without O/Cs. Individuals with HD and O/Cs endorsed significantly higher psychiatric comorbidities of depression, suicidal ideation, aggression, delusions, and hallucinations. Participants with the most severe O/Cs and worse performance on the Stroop task, a measure of executive function. Clinicians should be aware that patients with HD and O/Cs might have a somewhat different clinical picture from those without, and may require a specialized treatment plan.
Anderson
Karen E
KE
Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Gehl
Carissa R
CR
Marder
Karen S
KS
Beglinger
Leigh J
LJ
Paulsen
Jane S
JS
D000328:Adult; D000367:Age Factors; D017668:Age of Onset; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology; D056344:Executive Function; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests / Q000706:statistics & numerical data; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000453:epidemiology*; D011379:Prognosis; D013405:Suicide / Q000523:psychology
Biol Psychiatry. 1998 May 1;43(9):666-73
9583000
Mov Disord. 2000 May;15(3):552-60
10830423
Neurosci Lett. 1991 Dec 9;133(2):257-61
1840078
Psychiatr Clin North Am. 2004 Mar;27(1):37-47, viii
15062629
Mov Disord. 1996 Mar;11(2):136-42
8684382
Psychol Med. 1996 Nov;26(6):1261-9
8931172
Confin Neurol. 1969;31(4):258-68
4243863
Acta Psychiatr Scand. 1998 Jan;97(1):62-5
9504705
J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77
2932539
Brain. 1989 Jun;112 ( Pt 3):699-725
2786440
Neuropsychopharmacology. 1989 Mar;2(1):23-8
2803479
Neurology. 2001 Sep 25;57(6):1025-8
11571328
Biol Psychiatry. 2007 Feb 1;61(3):415-8
16839521
J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):310-4
11511702
Arch Gen Psychiatry. 1992 Sep;49(9):681-9
1514872
Arch Gen Psychiatry. 1990 Sep;47(9):840-8
2393342
Psychopharmacology (Berl). 2001 Jan 1;153(2):264-6
11205429
Biol Psychiatry. 1992 Feb 1;31(3):263-70
1532132
Am J Psychiatry. 2001 May;158(5):799-801
11329405
J Neuropathol Exp Neurol. 1995 Jan;54(1):105-20
7815073
Eur Arch Psychiatry Clin Neurosci. 1993;243(1):16-22
8399406
Brain. 1991 Oct;114 ( Pt 5):2191-202
1933241
Am J Psychiatry. 1998 Feb;155(2):264-71
9464208
Neurology. 2002 Mar 12;58(5):695-701
11889230
J Neuropsychiatry Clin Neurosci. 1994 Spring;6(2):93-9
8044049
J Nerv Ment Dis. 2001 Apr;189(4):219-28
11339317
J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):288-9
11001616
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80
18096682
Arch Gen Psychiatry. 1992 Sep;49(9):690-4
1514873
Neurology. 1997 Feb;48(2):394-9
9040728
Neurology. 2000 Jan 25;54(2):452-8
10668713